Publix Q1 Sales Rise 2%, While Earnings Fall on Drug Pricing Impact
Publix posted higher first-quarter sales but lower earnings, as the grocer said a Medicare drug pricing change weighed on results.
For the three months ended March 28, 2026, Publix reported sales of $16.1 billion, up 2% from $15.8 billion a year earlier. Comparable-store sales were flat.
The company said the sales increase was dampened by the Medicare maximum fair price change that took effect Jan. 1, 2026, lowering prices for 10 drugs and reducing...
To Read Full Story Login Below.
Submit comment or question
Note: All comments are displayed with user's screen name. If screen name is not present, user's full name will be used. Please go to My Account to update your screen name.
Comment Policy: Urner Barry has made the comment feature available to encourage further discussion of our news stories. Defamatory or offensive comments, or comments deemed not relevant to the story will be removed, and if necessary, Urner Barry may restrict the right of individual subscribers to offer comments. In all cases, comments represent opinions of the poster only, and do not represent fact, news, opinions or estimates put forward by Urner Barry.
Email Address is required. Password is required.